Rhythmic Sensory Stimulation on Fibromyalgia

Last updated: May 10, 2024
Sponsor: Women's College Hospital
Overall Status: Trial Not Available

Phase

N/A

Condition

Pain

Chronic Pain

Fibromyalgia

Treatment

Vibroacoustic Therapy System - VTS 1000

Clinical Study ID

NCT06416826
FibroMusicTherapy
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of this project is to further examine the effectiveness of Rhythmic Sensory Stimulation (RSS) with low-frequency sounds and somatosensory stimulation as a complementary therapy for fibromyalgia, and to investigate potential mechanisms underlying the effects of RSS on chronic pain.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with clinical diagnosis of fibromyalgia

  • able to read and write English adequately

  • have satisfactory hearing bilaterally (self-reported)

  • have the ability to operate the supplied device

Exclusion

Exclusion Criteria:

  • acute and active inflammatory conditions (e.g., rheumatoid arthritis,osteoarthritis, autoimmune disease)

  • medical or psychiatric illness

  • history of psychosis, epilepsy, seizures

  • pregnancy or breast feeding

  • hemorrhaging or active bleeding

  • thrombosis, angina pectoris

  • heart disease, such as hypotension, arrhythmia, pacemaker

  • substance abuse (harmful or hazardous use of psychoactive subtances, includingalcohol and illicit drugs) in the last year

  • suffering from a recently prolapsed vertebral disc

  • recovering from a recent accident with back or neck injury.

Study Design

Treatment Group(s): 1
Primary Treatment: Vibroacoustic Therapy System - VTS 1000
Phase:
Study Start date:
April 01, 2019
Estimated Completion Date:
March 01, 2020